INDIVIOR PHARMACEUTICALS INC
INDVNASDAQ🏆 #1398 by market capUS Equity
$34.77▲ $0.07 (+0.20%)
Market closed · at closeTrack INDV
Get earnings, price moves & breaking news on Telegram
24h▲ 0.2%
7d▼ 1.6%
14d▲ 3.4%
30d▼ 5.0%
ytd▼ 3.1%
1y▲ 37.7%
🏦Market Cap
$4.10B
Small Cap
📈Revenue Growth (YoY)
13.6%
Healthy
📊Gross Margin
82.0%
High
💵FCF Margin
16.7%
Healthy
⚖️P/S Ratio
3.1x
Fair
Otter Score
76
Strong
Trading Snapshot
- Day Range
- $33.84 – $34.86
- 52-Week Range
- $24.28 – $42.81
- Volume (shares)
- 111,417
- Avg Volume (shares)
- —
- Shares Outstanding
- 118.0M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- $1.24B
- Last Q Revenue
- $343M
- P/E Ratio
- 11.6
- P/S Ratio
- 3.1x
- EPS (TTM)
- $2.78
- Dividend Yield
- —
- Dilution (1yr)
- −2.4%
INDIVIOR PHARMACEUTICALS INC
INDVFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$1.2B▲ +4.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
80.1%▼ −0.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$265M▲ +728.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$94M▼ −1980.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
125.0M▼ −2.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$156M▼ −$100M YoY
StockOtter · stockotter.spaceAbout INDIVIOR PHARMACEUTICALS INC
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Strong
76/100
Analyst data unavailable.
Latest News & Updates
News unavailable.